“Long-term results of moderate hypofractionation to prostate and pelvic nodes plus androgen suppression in high-risk prostate cancer.”

Moderate hypofractionated radiotherapy (HypoRT) is an attractive alternative to conventionally fractionated radiotherapy for prostate cancer. However, most studies using HypoRT only included the prostate as the target volume.